Table 3.
Adverse Events | Zagreb group (N=599) |
Essen group (N=600) |
P value | ||
---|---|---|---|---|---|
n | (%) | n | (%) | ||
Injection site (local) | 231 | 38.56 | 206 | 34.33 | 0.134 |
Pain | 222 | 37.06 | 190 | 31.67 | 0.052 |
Itching | 9 | 1.50 | 17 | 2.83 | 0.164 |
Swelling | 10 | 1.67 | 15 | 2.50 | 0.419 |
Erythema | 8 | 1.34 | 13 | 2.17 | 0.379 |
Induration | 4 | 0.67 | 4 | 0.67 | 1.000 |
Rash | 1 | 0.17 | 0 | 0.00 | 0.500 |
Other | 4 | 0.67 | 11 | 1.83 | 0.116 |
Non-injection site (systemic) | 128 | 21.37 | 121 | 20.17 | 0.619 |
Weakness | 60 | 10.02 | 50 | 8.33 | 0.319 |
Fever | 40 | 6.68 | 41 | 6.83 | 1.000 |
Dizziness | 36 | 6.01 | 33 | 5.50 | 0.712 |
Headache | 30 | 5.01 | 25 | 4.17 | 0.494 |
Diarrhea | 20 | 3.34 | 11 | 1.83 | 0.105 |
Abdominal pain | 16 | 2.67 | 9 | 1.50 | 0.164 |
Vomiting | 3 | 0.50 | 8 | 1.33 | 0.224 |
Myalgia (muscle pain) | 12 | 2.00 | 10 | 1.67 | 0.675 |
Arthralgia (joint pain) | 10 | 1.67 | 4 | 0.67 | 0.116 |
Hypersensitivity reaction | 2 | 0.33 | 3 | 0.50 | 1.000 |
Other | 4 | 0.67 | 4 | 0.67 | 1.000 |